Thank you for donating!

You can donate using the following services.

INPDA

NPUK is a member of the International Niemann-Pick Disease Alliance (INPDA). The INPDA is a global network of non-profit organisations supporting those affected by Niemann-Pick disease and was formed in 2009. It aims to relieve sickness and distress amongst families affected by Niemann Pick disease worldwide. It does this through sharing expertise, knowledge and skills across the network, providing mutual support between patient groups, improving information and awareness of Niemann-Pick disease and stimulating research.

Find out more at inpda.org.

Members include:

ArgentinaAssociacion Niemann Pick de Argentina

www.npcargentina.org

info@npcargentina.org

 

 

Australia-flagAustralian NPC Disease Foundation

www.npcd.org.au

mandy@npcd.org.au / kellie@npcd.org.au

 

 

Brazil-flagAssociação Niemann Pick Brasil – ANPB

www.niemannpickbrasil.org.br

contato@niemannpickbrasil.org.br

 

 

 

canadaCanadian Chapter of the National Niemann Pick Disease Foundation (CCNNPDF)

www.nnpdf.ca

nnpdf@nnpdf.org

 

 

China-flag中国尼曼匹克关爱中心

China Niemann-Pick  Disease Association

http://chinanpd.org.cn/

chinanpd@sina.cn

 

 

franceVaincre Les Maladies Lysosomales (VML)

scientifique@vml-asso.org

www.vml-asso.org

 

 

 

germanyNiemann Pick Selbsthilfegruppe

www.niemann-pick.de

info@niemann-pick.de

 

 

 

italyAssociazione Italiana Niemann Pick

www.niemannpick.org

info@niemannpick.org

 

 

 

netherlandsVolwassenen, Kinderen en Stofwisselingsziekten (VKS)

www.stofwisselingsziekten.nl

info@stofwisselingsziekten.nl

 

 

2 Norway

NP Foreningen I Norge

siriskollerud@yahoo.com

 

 

 

spainFoundacion Niemann-Pick de Espana (FNP)

www.fnp.es

 

 

 

swissNiemann Pick Suisse

www.npsuisse.ch

contact@npsuisse.ch

 

 

 

 

ukNiemann-Pick UK (NPUK)

www.npuk.org

info@npuk.org

 

 

usaNational Niemann-Pick Disease Foundation (NNPDF)

www.nnpdf.org

nnpdf@nnpdf.org

 

 

Taiwanese Niemann-Pick Group2000px-Flag_of_the_Republic_of_China.svg

Latest news

15.03.19

CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol® Cyclo™ in Alzheimer’s Disease

ALACHUA, FL – (Globe Newswire) – March 14, 2019 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has initiated planning for a Phase I clinical trial for treatment of Alzheimer’s Disease. The trial will use Trappsol® Cyclo™, the company’s proprietary formulation of hydroxypropyl beta cyclodextrin, administered intravenously.

Read more

11.03.19

IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of Niemann-Pick Disease type C (NPC)

IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of Niemann-Pick Disease type C (NPC): OXFORD, UK, March 11, 2019-- IntraBio Inc., a late-stage biopharmaceutical company, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved its Clinical Trial Authorisation (CTA) Application for Clinical Trial IB1001-201 with its lead compound (IB1001) for the treatment of Niemann-Pick disease Type C (NPC).

Read more
View all news Subscribe